Log In
Print
BCIQ
Print
Print this Print this
 

NBI-98854

Also known as: VMAT2

  Manage Alerts
Collapse Summary General Information
Company Neurocrine Biosciences Inc.
DescriptionSelective vesicular monoamine transporter 2 (VMAT2; SLC18A2) inhibitor
Molecular Target Vesicular monoamine transporter 2 (VMAT2) (SLC18A2)
Mechanism of ActionVesicular monoamine transporter 2 inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today